Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 78 | 947 | 452 | 298 | 1,100 |
| Gross Profit | 78 | 947 | 452 | 298 | 1,100 |
| Operating Expenses | 26,577 | 79,586 | 21,518 | 22,109 | 22,989 |
| Operating Income | -26,499 | -78,639 | -21,066 | -21,811 | -21,889 |
| Other Income | -12,683 | -23,130 | -14,836 | 37,697 | 4,179 |
| Pre-tax Income | -39,182 | -101,769 | -35,902 | 15,886 | -17,710 |
| Net Income Continuous | -39,182 | -92,576 | -35,902 | 15,886 | -17,710 |
| Net Income | $-39,182 | $-92,576 | $-35,902 | $15,886 | $-17,710 |
| EPS Basic Total Ops | -1.46 | -3.47 | -1.38 | 0.51 | -0.68 |
| EPS Basic Continuous Ops | -1.46 | -3.56 | -1.38 | 0.61 | -0.68 |
| EPS Diluted Total Ops | -1.46 | -3.46 | -1.38 | 0.50 | -0.68 |
| EPS Diluted Continuous Ops | -1.46 | -3.55 | -1.38 | 0.60 | -0.68 |
| EPS Diluted Before Non-Recurring Items | -1.46 | -1.38 | -1.38 | 0.50 | -0.68 |
| EBITDA(a) | $-25,884 | $-78,031 | $-20,460 | $-21,222 | $-20,733 |